Veeva Systems (NYSE: VEEV) today announced that more than 50 organizations are using Veeva Vault Safety Suite applications to simplify case handling and management. More and more emerging biotechs and large corporations, including a leading global pharmaceutical company, are bringing together pharmacovigilance data and content for real-time safety management.

Organizations of all sizes are modernizing pharmacovigilance with the Vault Safety Suite to improve end-to-end processes through better collaboration. Sponsors and CROs benefit from easy access to information for seamless processing of adverse events, while interactive reports and dashboards provide the transparency to detect delays and streamline the submission of reports to health authorities.

"More and more organizations are using Veeva Vault Safety Suite applications to achieve faster and more efficient case management," said Kelly Traverso,vice president, Veeva Vault Safety Strategy. "Our customers view Veeva as a strategic partner, and we are committed to delivering advanced features that make it easy to keep up with evolving regulations and changing market dynamics."

Veeva continues to bring innovations to market that simplify pharmacovigilance processes. Over the past year, Veeva has added new features, including the multilingual MedDRA browser, E2B import for multiple cases, and inclusion in local English.

The Veeva Vault Safety Suite includes Veeva Vault Safety and Veeva Vault SafetyDocs to manage end-to-end drug safety processes.